ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Technologies Banner

Medical Sciences

Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs

Implementing Organization

Central Drug Research Institute (CDRI)

Project Overview

Treatment of pulmonary TB with orally-administered drugs is sub-optimal-exposing non-target tissues to toxic drugs and requiring large doses to build up effective concentrations in lungs . Prolonged dosing is required to build up and maintain effective concentrations in lungs . Patients remain infectious for considerable periods after initiating drug treatment.

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Area of Research
Medical Sciences
Focus Area
Treatment of Pulmonary TB
Status
1
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :01
Grant :00
arrowtop